Literature DB >> 1716906

Effect of yohimbine on brain monoamines: an in vivo study.

T Brannan1, J Martinez-Tica, M D Yahr.   

Abstract

Following the administration of yohimbine, an alpha 2-adrenoreceptor antagonist, the levels of norepinephrine (NE), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5HIAA) increased significantly in the lateral ventricular fluid of rats. These increases were abolished when animals were pretreated with alpha-methyl-para-tyrosine or reserpine. Dopamine (DA) was not detected in ventricular fluid either before or after yohimbine administration. Yohimbine administration did, however, increase intracellular DA levels in the corpus striatum. These findings indicate that yohimbine promotes NE and DA release in the brain and suggest that it also modifies the activity of the serotonin system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716906     DOI: 10.1007/bf02260883

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  5 in total

1.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

2.  Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine.

Authors:  M Berlan; R Le Verge; J Galitzky; P Le Corre
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

3.  Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools.

Authors:  M M M Verheij; A R Cools
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

Review 4.  Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Authors:  Mark K Greenwald
Journal:  Neurobiol Stress       Date:  2018-08-11

Review 5.  Which came first: Cannabis use or deficits in impulse control?

Authors:  Linda Rinehart; Sade Spencer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-08-11       Impact factor: 5.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.